ATENFE 100 MG/ML SOL INJ CT 2 BL X SER PREENC VD TRANS X 0,8 ML + AGU + ENV LEN ÁLCOOL
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1014300740064 -
GGREM
516325090003407 -
Código de barras
7896026173155
O que a fonte publica
- Detentor do registro
- MEGALABS FARMACEUTICA S.A.
- Princípios ativos
- ADALIMUMABE
- Embalagem
- 100 MG/ML SOL INJ CT 2 BL X SER PREENC VD TRANS X 0,8 ML + AGU + ENV LEN ÁLCOOL
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- ATENFE 100 MG/ML SOL INJ CT 2 BL X SER PREENC VD TRANS X 0,8 ML + AGU + ENV LEN ÁLCOOL
- ATENFE
- ADALIMUMABE
Dados completos da fonte
{
"name": "ATENFE 100 MG/ML SOL INJ CT 2 BL X SER PREENC VD TRANS X 0,8 ML + AGU + ENV LEN ÁLCOOL",
"holder": "MEGALABS FARMACEUTICA S.A.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896026173155"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "516325090003407",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.026.055/0001-20",
"priceRegime": "Regulado",
"productName": "ATENFE",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "100 MG/ML SOL INJ CT 2 BL X SER PREENC VD TRANS X 0,8 ML + AGU + ENV LEN ÁLCOOL",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "4040.86",
"icms-12": "4591.89",
"icms-17": "4868.50",
"icms-18": "4927.88",
"icms-19": "4988.72",
"icms-20": "5051.08",
"icms-21": "5115.01",
"icms-22": "5180.59",
"icms-23": "5247.87",
"icms-17.5": "4898.01",
"icms-19.5": "5019.70",
"icms-20.5": "5082.84",
"icms-22.5": "5214.01",
"icms-12-alc": "4536.78",
"icms-17-alc": "4810.08",
"icms-18-alc": "4868.74",
"icms-19-alc": "4928.85",
"icms-20-alc": "4990.46",
"icms-21-alc": "5053.63",
"icms-22-alc": "5118.42",
"icms-23-alc": "5184.89",
"withoutTaxes": "3992.37",
"icms-17.5-alc": "4839.23",
"icms-19.5-alc": "4959.46",
"icms-20.5-alc": "5021.85",
"icms-22.5-alc": "5151.45"
},
"pisCofinsList": "Positiva",
"substanceText": "ADALIMUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "5569.90",
"icms-12": "6329.44",
"icms-17": "6710.72",
"icms-18": "6792.57",
"icms-19": "6876.43",
"icms-20": "6962.39",
"icms-21": "7050.51",
"icms-22": "7140.90",
"icms-23": "7233.64",
"icms-17.5": "6751.40",
"icms-19.5": "6919.13",
"icms-20.5": "7006.17",
"icms-22.5": "7186.97",
"icms-12-alc": "6271.83",
"icms-17-alc": "6649.65",
"icms-18-alc": "6730.75",
"icms-19-alc": "6813.85",
"icms-20-alc": "6899.02",
"icms-21-alc": "6986.35",
"icms-22-alc": "7075.92",
"icms-23-alc": "7167.81",
"withoutTaxes": "5519.22",
"icms-17.5-alc": "6689.95",
"icms-19.5-alc": "6856.16",
"icms-20.5-alc": "6942.41",
"icms-22.5-alc": "7121.58"
},
"invalidBarcodes": [],
"activeSubstances": [
"ADALIMUMABE"
],
"therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1014300740064",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L4B",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:516325090003407"